As of 2025-07-06, the EV/EBITDA ratio of Remedent Inc (REMI) is -1.78. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. REMI's latest enterprise value is 0.12 mil USD. REMI's TTM EBITDA according to its financial statements is -0.07 mil USD. Dividing these 2 quantities gives us the above REMI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 5.6x - 8.4x | 7.0x |
| Forward P/E multiples | 5.6x - 8.4x | 7.0x |
| Fair Price | (0.01) - (0.02) | (0.02) |
| Upside | -242.0% - -333.8% | -287.9% |
| Date | EV/EBITDA |
| 2025-06-04 | -1.78 |
| 2025-06-02 | -4.43 |
| 2025-05-21 | -5.13 |
| 2025-05-07 | -5.96 |
| 2025-05-06 | -5.93 |
| 2025-04-16 | -6.08 |
| 2025-04-15 | -6.93 |
| 2025-04-14 | -7.57 |
| 2025-04-10 | -9.40 |
| 2025-03-31 | -13.98 |